Diebold Nixdorf, Incorporated research snapshot
DBD AI stock analysis reads Diebold Nixdorf as a post-restructuring ATM and retail technology leader whose Q2 FY2026 report showed revenue growth, record order entries, and growth in adjusted EBITDA and adjusted EPS, but whose stock had run up so far that it sold off after the July 29 report before rebounding. At the August 4, 2026 data cutoff, DBD traded near $77.48 with a verified market capitalization near $2.63 billion and roughly 25x trailing EPS. This page uses scenario ranges and source checks, not a certain stock price prediction, and is for informational use only.
Current price
$77.48
Market cap
$2.63 billion
AI score
65 / 100
Rating
Turnaround progressing; high expectations after the Q2 beat
Trend status
Rebounding near $77 after pulling back from a 52-week high near $92
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Diebold Nixdorf is the largest ATM manufacturer in the United States with a global installed base, service network, and retail POS systems, and Q2 FY2026 showed record order entries and retail momentum. The business still carries moderate capital intensity, hardware cyclicality, and post-bankruptcy financial scars. | Medium |
| Moat | Moat comes from the global installed base of ATMs and retail POS terminals, service contracts, software integration (DN Vynamic), and long-term bank relationships, now extended by managing roughly 400,000 Android devices for about 100 customers. Hardware switching costs remain lower than for software platforms. | Medium-low |
| Management | CEO Octavio Marquez led the company through Chapter 11 restructuring and is now executing Q2 revenue growth, record order entries, and adjusted EBITDA and adjusted EPS growth. Capital allocation discipline and the ability to convert orders into sustained GAAP earnings are still being proven over a full cycle. | Medium |
| Financial trend | TTM revenue is about $3.87 billion with TTM net income near $111 million, and Q2 FY2026 net income rose to $15.5 million from $5.0 million in Q1, but GAAP net margin was only about 1.7% in Q2 and the FY2024 net loss of -$15 million shows how recent the turnaround is. | Medium |
| Valuation | At $77.48, DBD trades near 25x trailing EPS, about 0.68x sales, near 2.7x book, near 8.6x EV/EBITDA, and near 7x levered FCF with a FCF yield near 14%. The P/E is high for the earnings level, but FCF and EV/EBITDA multiples are more reasonable for a post-restructuring industrial technology company. | Medium |
| Technical trend | The stock hit a 52-week high near $92.08 in July 2026, sold off to about $71.25 after the Q2 report, and rebounded to $77.48 on the August 3 close. Momentum is medium-term positive but the stock is now in a corrective range below the high. | Medium |
| Risk level | Key risks include debt leverage near 96.6% debt-to-equity, thin GAAP margins, ATM market maturity, competition from NCR Atleos and Hyosung, bank branch spending pressure, high expectations after the one-year rally, and a limited analyst base that reduces price discovery. | Medium |
| AI confidence | High for descriptive facts, verified price levels, quarterly revenue, and balance sheet figures. Medium for forward scenarios and chart levels given the thin post-restructuring trading history. | High data confidence |
| Investment certainty | Low-medium certainty. The page frames scenarios and monitoring rules, not a buy or sell instruction. Q2 execution is improving, but the post-earnings selloff shows the market already priced much of the turnaround. | Low-medium |
DBD AI stock forecast
The DBD AI stock forecast uses scenario math around the $77.48 quote and trailing EPS near $3.06. The verified three-year framework produced a bearish area near $34, a base area near $58, and a bullish area near $95. The current price sits above the base case, which means the market is already pricing in continued turnaround progress and the downside scenarios are larger in percentage terms than the upside from here.
$90 to $100
More likely if Diebold Nixdorf sustains double-digit EPS growth through service and software revenue expansion, record order conversion, margin improvement from restructuring benefits, and the market holds a premium multiple near 22x earnings as confidence in the turnaround firms.
$55 to $65
More likely if EPS growth runs around mid-single digits, revenue stays near $3.8-$4.0 billion, operating margins improve slowly, and the stock trades near 16x earnings, which is reasonable for a post-restructuring industrial technology company with moderate growth.
$28 to $38
More likely if growth stalls, ATM replacement cycles slow, debt servicing costs constrain margins, or the market re-rates the stock toward 11x earnings because of limited visibility, high leverage, and competition from NCR Atleos and regional ATM providers.
DBD AI technical analysis
DBD AI technical analysis shows a stock that climbed to a 52-week high near $92.08 in July 2026, then dropped to about $71.25 after the July 29 Q2 report, and closed near $77.48 on August 3, 2026. The medium-term trend is still positive after a roughly 27% one-year gain, but the stock is now in a corrective range between the post-earnings low and the 52-week high, with the Q2 selloff showing how quickly sentiment can shift at elevated expectations.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $77.48 | Quote snapshot from the August 3, 2026 close with a market cap near $2.63 billion. |
| Near support | $71 to $73 | The post-earnings low near $71.25 and the July 30 close near $71.26 form the first support zone if the stock pulls back again. |
| Deeper support | $64 to $66 | A prior consolidation area below the July pullback represents a deeper support zone if the near-term correction extends. |
| 52-week low | $54.26 | The base of the 52-week range near $54.26 is the major downside reference for the past year. |
| Near resistance | $85 to $87 | The zone between the current price and the 52-week high where the stock traded before the Q2 selloff. Reclaiming it would signal the uptrend is resuming. |
| Major resistance | $92.08 | The 52-week high set in July 2026. A decisive break above this level would be a strong bullish signal. |
| Long-term resistance | $100 | The analyst consensus price target sits at $100, making this a psychological and fundamental resistance level above the 52-week high. |
| Momentum | Positive medium-term, cooled after Q2 | One-year return was near +27% and six-month near +3% as of late July, but the post-earnings drop and August rebound show momentum is choppy near current levels. |
| Volume | Average volume near 306K to 334K shares | Average volume is relatively low, and the July 30 selloff and August 3 rebound both ran on above-average volume, which can amplify moves in both directions. |
| Volatility | Wide 52-week range near $54 to $92 | The stock has moved from a 52-week low near $54.26 to a high near $92.08, a roughly 70% swing that reflects post-restructuring volatility. |
| Invalidation | Close below $71 | A decisive close below the post-earnings low near $71 would suggest the corrective phase is deepening toward $64-$66 and undermine the medium-term uptrend. |
DBD AI trading strategy
The DBD AI trading strategy is a rules-based research framework for monitoring a post-restructuring ATM and retail technology stock that just reported a revenue beat, record order entries, and adjusted earnings growth but also showed elevated expectations in its post-earnings volatility. It is not personal advice and should be paired with fresh chart data, earnings reports, position sizing, and a defined invalidation level.
Watch for DBD to reclaim the $85-$87 zone on above-average volume, ideally after a Q3 FY2026 beat or raised guidance, with a sustained move toward $92-$100 confirming the uptrend is intact.
A close below $71 or a failed bounce below the 52-week high should invalidate the near-term trend-following setup. The low average volume means position sizing should account for wider spreads.
If DBD pulls back toward the $71-$73 zone without a negative earnings revision, compare the pullback with service and software revenue growth, order conversion, operating margin trends, and debt reduction progress before assuming support is durable.
Do not average down without a maximum loss rule because post-bankruptcy stocks can gap on earnings misses, dilution news, or competitive developments.
Track quarterly revenue and EPS trajectory, conversion of the record order book, service and software revenue share, operating margin improvement, debt reduction, free cash flow generation, and banking sector capex trends.
Reduce confidence if revenue growth depends mainly on pricing or one-time items instead of organic service and software expansion, or if net leverage does not improve over the next two quarters.
Investment research summary
Diebold Nixdorf provides ATMs, cash recyclers, POS systems, and banking software to financial institutions and retailers across 130 countries. Customers pay because the hardware, service, and software integration keeps their self-service channels running, and Q2 record order entries show demand remains.
The moat is moderate and based on installed base scale, a global service network, banking software integration (DN Vynamic), long-term bank contracts, and now a managed-device footprint of roughly 400,000 Android devices for about 100 customers, but hardware competition from NCR Atleos, Hyosung, and regional players limits pricing power.
The thesis fails if order momentum does not convert into sustained GAAP earnings, if restructuring benefits prove temporary, if ATM market growth slows as digital banking reduces cash usage, or if competitive pressures from NCR and regional manufacturers intensify.
CEO Octavio Marquez should be judged by post-bankruptcy execution, Q2 order conversion, debt reduction pace, service and software revenue mix improvement, R&D effectiveness, and consistent operating margin expansion without sacrificing market share.
The ATM and retail tech industry faces a long-term question about cash usage decline, but ATM upgrades, security mandates, self-checkout expansion, and banking software modernization create replacement cycles. Diebold also benefits from bank branch transformation investments.
At roughly 25x trailing EPS and about 0.68x sales, the stock carries a recovery premium, and the current price sits above the base-case three-year scenario near $58. Margin of safety is limited at the current price but improves if the stock revisits the $60-$70 area while the turnaround stays on track.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| DBD price | $77.48 | Google Finance quote snapshot | August 4, 2026 |
| Market capitalization | $2.63 billion, verified as $77.48 x 33.95 million shares | financial_rigor.py market cap verification | August 4, 2026 |
| Shares outstanding | 33.95 million (Google Finance); about 35.1 million per CompaniesMarketCap as of August 2026 | Google Finance / CompaniesMarketCap | August 4, 2026 |
| 52-week range | $54.26 low to $92.08 high | Google Finance statistics | August 4, 2026 |
| TTM revenue | $3.87 billion (trailing twelve months based on recent quarterly filings) | Yahoo Finance financial summary | August 4, 2026 |
| Q2 FY2026 results | $930.8 million revenue (beat the $926.2 million estimate), $15.5 million net income, $1.10 GAAP EPS, record order entries, adjusted EBITDA and adjusted EPS growth | Google Finance income statement / PR Newswire | August 4, 2026 |
| EPS (TTM) | $3.06 (Google Finance trailing basis); $2.86 diluted per Yahoo Finance | Google Finance statistics / Yahoo Finance | August 4, 2026 |
| FY2024 results | $3.75 billion revenue, -$15 million net income | Wikipedia / Diebold Nixdorf FY2024 10-K | August 4, 2026 |
| Cash and debt | $282.4 million cash, debt-to-equity ratio of 96.56% | Yahoo Finance balance sheet summary | August 4, 2026 |
| Free cash flow (TTM) | $377.49 million levered FCF, implying near 7x P/FCF and a near 14% FCF yield | Yahoo Finance cash flow summary / financial_rigor.py | August 4, 2026 |
| Analyst consensus | 2 Buy ratings from D.A. Davidson and Wedbush with $100 targets; Yahoo average near $98.33; Argus rates it Hold with a $95 target | Google Finance / Yahoo Finance analyst ratings | August 4, 2026 |
| New development | Recognized as an Android Enterprise Gold Partner, managing about 400,000 Android devices for roughly 100 customers (August 3, 2026) | PR Newswire via StockTitan / Financial Times | August 4, 2026 |
This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell DBD stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. Always verify current filings, prices, risks, and personal suitability before making financial decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
